Healthcare Stocks
English health service sets out two-year recovery plan for emergency care
- January 30, 2023 12:02 AM GMT | Reuters

287 By Alistair Smout LONDON (Reuters) - England's National Health Service (NHS) on Monday announced a two-year recovery plan to help restore emergency care and frontline services, currently struggling
Centessa Pharmaceuticals PLC Entered Into A Sales Agreement With Svb Securities Llc
- January 27, 2023 10:25 PM GMT
- Reuters
CORRECTED-FDA classifies recall of LivaNova's blood-pumping system controller as most serious
- January 27, 2023 10:16 PM GMT
- Reuters
What to Watch in the Week Ahead and on Monday, January 30
- January 27, 2023 07:30 PM GMT
- Reuters
FDA classifies recall of LivaNova's blood-pumping system controller as most serious
- January 27, 2023 05:55 PM GMT
- Reuters

U.S. FDA approves Gilead's long-acting HIV drug Sunlenca
- December 22, 2022 03:44 PM GMT | Reuters
(Adds drug's pricing, details, background) Dec 22 (Reuters) - The U.S. Food and Drug Administration (FDA) on Thursday approved Gilead Sciences Inc's Sunlenca therapy for HIV infections, paving the way
Read More...
U.S. RESEARCH ROUNDUP-Amgen, Coupa Software, Enphase Energy
- December 22, 2022 03:11 PM GMT | Reuters
Dec 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amgen, Coupa Software and Enphase Energy, on Thursday. HIGHLIGHTS
Read More...
England reports 94 deaths due to scarlet fever so far this season
- December 22, 2022 02:37 PM GMT | Reuters
(Adds agency comment, background) Dec 22 (Reuters) - England reported 94 deaths, including those of 21 children, from scarlet fever and invasive strep A infections so far this season the UK Health
Read More...
UK Says 94 Deaths Due To Scarlet Fever So Far This Season In England
- December 22, 2022 02:02 PM GMT | Reuters
Dec 22 (Reuters) - UK Health Security Agency: * UK SAYS SO FAR THIS SEASON THERE HAVE BEEN 94 DEATHS ACROSS ALL AGE GROUPS IN ENGLAND DUE TO SCARLET FEVER AND INVASIVE GROUP A STREP * UK SAYS SO FAR
Read More...
UK says 94 deaths due to scarlet fever so far this season in England
- December 22, 2022 01:51 PM GMT | Reuters
(Reuters) - The British government said on Thursday there have been 94 deaths due to scarlet fever and invasive group Strep A infections across all age groups in England so far this season. The UK
Read More...
China COVID deaths probably running above 5,000 per day - UK research firm Airfinity
- December 22, 2022 11:28 AM GMT | Reuters
BEIJING (Reuters) - More than 5,000 people are probably dying each day from COVID-19 in China, health data firm Airfinity estimated, offering a dramatic contrast to official data from Beijing on the
Read More...
Logistics Development Group Buys 12.8 Mln Ordinary Shares In Alliance Pharma At £0.4611 Per Ordinary Share
- December 22, 2022 10:35 AM GMT | Reuters
Dec 22 (Reuters) - Logistics Development Group PLC : * LOGISTICS DEV GRP - ALLIANCE PHARMA PLC INVESTMENT * LOGISTICS DEVELOPMENT GROUP - BUYS 12.8 MILLION ORDINARY SHARES IN ALLIANCE PHARMA PLC AT AN
Read More...
Immupharma Continues To Work With Partner Avion & External Advisors, On Proposed Updated P140 Clinical Programme For 2023
- December 22, 2022 07:48 AM GMT | Reuters
Dec 22 (Reuters) - ImmuPharma PLC: * IMMUPHARMA PLC - END OF YEAR UPDATE * IMMUPHARMA PLC - CONTINUES TO WORK WITH PARTNER AVION & EXTERNAL ADVISORS, ON PREPARATIONS AROUND PROPOSED UPDATED P140
Read More...
Okyo Pharma Limited Gets FDA Clearance Of IND Application For OK-101
- December 22, 2022 07:40 AM GMT | Reuters
Dec 22 (Reuters) - OKYO Pharma Ltd: * U.S. FDA CLEARANCE OF IND APPLICATION FOR OK-101 * OKYO PHARMA ANNOUNCES U.S. FDA CLEARANCE OF IND APPLICATION FOR OK-101 FOR TREATMENT OF DRY EYE DISEASE * PHASE
Read More...
Destiny Pharma To Finalise Phase 3 Plans For Xf-73 Nasal
- December 22, 2022 07:26 AM GMT | Reuters
Dec 22 (Reuters) - Destiny Pharma PLC: * DESTINY PHARMA PLC - YEAR END TRADING UPDATE * DESTINY PHARMA PLC - TO FINALISE OUR PHASE 3 PLANS FOR XF-73 NASAL AND INTENSIFY PARTNERING DISCUSSIONS *
Read More...